Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CureVac
Biotech
CureVac, chasing Moderna mRNA flu shot, hits similar problems
CureVac and GSK have come up against the same problem as Moderna when it comes to the "historically challenging" B strains of influenza.
James Waldron
Apr 4, 2024 9:30am
CureVac touts COVID-19 vax data despite adverse events
Jan 5, 2024 11:16am
CureVac hand-picks mRNA flu vaccine but keeps data tucked away
Sep 12, 2023 10:45am
LimmaTech regains shigella shot from GSK, new CEO from CureVac
Jul 20, 2023 10:31am
CureVac posts mRNA flu, COVID-19 vaccine data in older adults
Jan 30, 2023 9:35am
Novavax CEO to retire after 12 years—Chutes & Ladders
Jan 13, 2023 9:30am